Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
2.0
2.4
Journals
Children
Special Issues
Advances in Pediatric Multisystem Inflammatory Syndrome (MIS-C)
share announcement

Advances in Pediatric Multisystem Inflammatory Syndrome (MIS-C)

A special issue of Children (ISSN 2227-9067). This special issue belongs to the section "Pediatric Allergy and Immunology".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 3923

Special Issue Editors

Dr. Francesco La Torre

E-Mail Website
Guest Editor
Department of Pediatrics, Pediatric Rheumatology Center, Ospedale Pediatrico "Giovanni XXIII", AOU Consorziale Policlinico, Bari, Italy
Interests: pediatrics; rheumatology; autoinflammatory diseases; vasculitis
Prof. Dr. Marco Cattalini

E-Mail Website
Guest Editor
Pediatric Clinic, University of Brescia and Spedali Civili di Brescia, 25123 Brescia, Italy
Interests: pediatrics; rheumatology; autoinflammatory diseases; synovial fluid; systemic lupus erythematosus; autoimmune disease; cytokines; TNF; autoimmune disorders; arthritis
Prof. Dr. Andrea Taddio

E-Mail Website
Guest Editor
1. Department of Medicine, Surgery and Health Sciences, University of Trieste, 34127 Trieste, Italy
2. Institute of Maternal and Child Health, IRCCS Burlo Garofolo, 34137 Trieste, Italy
Interests: pediatrics; rheumatology; clinical immunology

Special Issue Information

Dear Colleagues,

Multisystem inflammatory syndrome in children (MIS-C) is a newly identified clinical entity that has been linked to SARS-CoV-2 infection in children, adolescents and young adults.

MIS-C represents a “hot topic” at present, given the direct correlation with SARS-CoV-2 infection and the high percentage of patients requiring intensive care unit (ICU) admission and aggressive therapy. Indeed, data regarding disease epidemiology and pathogenesis, but also the best treatment strategy and outcome, are very heterogeneous. Recently, a more aggressive therapeutic approach in the early phases of the disease showed greater efficacy in terms of reducing ICU access and allowing better long-term outcomes.

The purpose of this Special issue is to provide cutting-edge data on MIS-C, for a better understanding of all aspects of the disease. Original data from observational and registry studies will be kept in the utmost consideration, but we will also consider reviews and case reports if they present advances in our understanding of the disease.

Dr. Francesco La Torre
Prof. Dr. Marco Cattalini
Prof. Dr. Andrea Taddio
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • multisystem inflammatory syndrome in children (MIS-C)
  • Kawasaki disease (KD)
  • Anti IL-1
  • COVID-19
  • hyperinflammation
  • treatment
  • outcome

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Other

12 pages, 294 KiB  
Brief Report
Determination of Risk Factors for Severe Life-Threatening Course of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children
by Ilia S. Avrusin, Natalia N. Abramova, Konstantin E. Belozerov, Gleb V. Kondratiev, Liudmila V. Bregel, Olesya S. Efremova, Alla A. Vilnits, Julia E. Konstantinova, Eugenia A. Isupova, Tatiana L. Kornishina, Vera V. Masalova, Eugeniy Yu. Felker, Olga V. Kalashnikova, Vyacheslav G. Chasnyk, Yuriy S. Aleksandrovich and Mikhail M. Kostik
Children 2023, 10(8), 1366; https://doi.org/10.3390/children10081366 - 09 Aug 2023
Cited by 3 | Viewed by 1002
Abstract
Multisystem inflammatory syndrome associated with COVID-19 in children (MIS-C) is a life-threatening condition that often requires intensive care unit (ICU) admission. The aim of this study was to determine risk factors for severe/life-threatening course of MIS-C. The study included 166 patients (99 boys, [...] Read more.
Multisystem inflammatory syndrome associated with COVID-19 in children (MIS-C) is a life-threatening condition that often requires intensive care unit (ICU) admission. The aim of this study was to determine risk factors for severe/life-threatening course of MIS-C. The study included 166 patients (99 boys, 67 girls) aged 4 months–17 years (median 8.2 years). The criterion of severity was the fact of ICU admission. To conduct a comparative analysis, MIS-C patients were divided into two groups: patients hospitalized in the ICU (n = 84, 50.6%) and those who did not need ICU admission (n = 82, 49.4%). Patients with a more severe course of MIS-C were significantly older. They had a higher frequency of signs such as rash, swelling, hepatomegaly, splenomegaly, and neurological and respiratory symptoms. Hypotension/shock and myocardial involvement were much more common in patients with severe MIS-C. These patients had a more significant increase in CRP, creatinine, troponin, and D-dimer levels. Additionally, the presence of macrophage activation syndrome was higher in patients admitted to the ICU. Conclusion: Nineteen predictors of severe course of MIS-C were found, out of which hepatomegaly, splenomegaly, D-dimer > 2568 ng/mL, troponin > 10 pg/mL were mainly associated with the probability of being classified as early predictors of severe MIS-C requiring ICU admission. Full article
(This article belongs to the Special Issue Advances in Pediatric Multisystem Inflammatory Syndrome (MIS-C))
11 pages, 2724 KiB  
Case Report
Thrombotic Events in MIS-C Patients: A Single Case Report and Literature Review
by Valerio Maniscalco, Rachele Niccolai, Edoardo Marrani, Ilaria Maccora, Federico Bertini, Ilaria Pagnini, Gabriele Simonini, Donatella Lasagni, Sandra Trapani and Maria Vincenza Mastrolia
Children 2023, 10(4), 618; https://doi.org/10.3390/children10040618 - 25 Mar 2023
Viewed by 1134
Abstract
Multisystem Inflammatory Syndrome in Children (MIS-C) is a systemic hyperinflammatory disorder that is associated with a hypercoagulable state and a higher risk of thrombotic events (TEs). We report the case of a 9-year-old MIS-C patient with a severe course who developed a massive [...] Read more.
Multisystem Inflammatory Syndrome in Children (MIS-C) is a systemic hyperinflammatory disorder that is associated with a hypercoagulable state and a higher risk of thrombotic events (TEs). We report the case of a 9-year-old MIS-C patient with a severe course who developed a massive pulmonary embolism that was successfully treated with heparin. A literature review of previous TEs in MIS-C patients was conducted (60 MIS-C cases from 37 studies). At least one risk factor for thrombosis was observed in 91.7% of patients. The most frequently observed risk factors were pediatric intensive care unit hospitalization (61.7%), central venous catheter (36.7%), age >12 years (36.7%), left ventricular ejection fraction <35% (28.3%), D-dimer >5 times the upper limit of normal values (71.9%), mechanical ventilation (23.3%), obesity (23.3%), and extracorporeal membrane oxygenation (15%). TEs may concurrently affect multiple vessels, including both arterial and venous. Arterial thrombosis was more frequent, mainly affecting the cerebral and pulmonary vascular systems. Despite antithrombotic prophylaxis, 40% of MIS-C patients developed TEs. Over one-third of patients presented persistent focal neurological signs, and ten patients died, half of whom died because of TEs. TEs are severe and life-threatening complications of MIS-C. In case with thrombosis risk factors, appropriate thromboprophylaxis should be promptly administered. Despite proper prophylactic therapy, TEs may occur, leading in some cases to permanent disability or death. Full article
(This article belongs to the Special Issue Advances in Pediatric Multisystem Inflammatory Syndrome (MIS-C))
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop